Form 4: Arcellx Chief Medical Officer Exercises Options and Sells Shares

Christopher Heery, Chief Medical Officer of Arcellx, Inc., exercised stock options and sold shares of common stock between March 22 and March 26, 2024, according to a recent SEC filing.

Summary

• Christopher Heery, the Chief Medical Officer of Arcellx, Inc., engaged in transactions involving the company's stock.
• On March 22, 2024, Heery exercised options to acquire 20,000 shares at a price of $6.28 per share and sold 41,365 shares at prices ranging from $69.5944 to $72.2474.
• On March 26, 2024, Heery exercised options to acquire 5,450 shares at $6.28 per share and sold 5,450 shares at prices ranging from $68.5473 to $70.1866.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 22, 2023.
• Following these transactions, Heery directly owns 8,938 shares of common stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. The sentiment is neither positive nor negative as it simply reports the facts of the transactions.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates